Translational Therapeutics at the Platelet Vascular Interface: A CME-Certified Activity |
From the Medizinische Klinik III, Eberhard Karls Universität Tübingen, Germany.
Correspondence to Andreas E. May, MD, Medizinische Klinik III, Eberhard Karls Universität Tübingen, Otfried-Müller-Strasse 10, D-72076 Tübingen, Germany. E-mail andreas.may{at}med.uni-tuebingen.de
Atherosclerosis is an inflammatory disease. Platelets can "inflame" the vascular wall by various mechanisms and thereby initiate and support the development of atherosclerosis. Platelet interaction with leukocytes, endothelial cells, and circulating progenitor cells triggers autocrine and paracrine activation processes, leading to inflammatory and atherogenic cascades at the vascular wall. This review highlights the molecular key components and pathways used by platelets to trigger and accelerate inflammation at the vascular wall and, thereby, atherosclerosis.
Key Words: platelets atherosclerosis inflammation vasculature cardiovascular events
This article has been cited by other articles:
![]() |
J. I. Borissoff, H. M.H. Spronk, S. Heeneman, and H. ten Cate Is thrombin a key player in the 'coagulation-atherogenesis' maze? Cardiovasc Res, June 1, 2009; 82(3): 392 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gawaz The evolving science of atherothrombotic disease Eur. Heart J. Suppl., November 1, 2008; 10(suppl_I): I4 - I7. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Wagner and P. S. Frenette The vessel wall and its interactions Blood, June 1, 2008; 111(11): 5271 - 5281. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |